Zacks Small Cap Research on MSN1d
MIRA Makes Significant Acquisition and Boosts CapitalMIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback